LONDON, Nov. 27, 2017 -- The global botanical extracts market is poised to grow at a CAGR of 8.8% from 2017 to 2022 to reach USD 5,833.4 million by 2022, driven by growing awareness of health and wellness and trend towards the natural health products, strict regulations regarding inclusion of synthetic flavours, growing population in developing countries discovering the health benefits of botanicals, increase in demand for convenience food, and growing demand of botanical extracts in herbal medicinal products. Moreover, increasing investments in emerging economies, and the emergence of new application areas with changing consumption trends provides significant opportunities within the food and beverage markets. However, the availability of substitutes such as synthetic flavour is expected to hinder the growth of this market to some extent. In addition, a limited supply of raw materials and fluctuating price of extracts is further challenging the growth of botanical extracts market.
Request Sample Report: http://www.meticulousresearch.com/request-sample-report/?cp_id=3398
North America holds the major share in the global botanical extracts market, followed by Europe, and Asia-Pacific. The large share of this region is primarily attributed to the increased consumption of functional food, growing desire to live a healthy lifestyle, and growing health & wellness trend in the region. However, Asia-Pacific region possesses lucrative growth potential for the botanical extracts market during the forecast period. This is mainly attributed to the rapid urbanization, increasing disposable income, increasing prevalence of diabetes, growing functional and organic food industry, and expanding use of botanical extracts in the cosmetics industry.
The key players in the global botanical extracts market are Frutarom Industries Ltd., Blue Sky Botanics Ltd., Ransom Naturals Ltd., Prinova Group LLC., Pt. Indesso Aroma, Synergy Flavors, Inc., Haldin Pacific Semesta, PT, Kalsec Inc., Synthite Industries Ltd., Döhler GmbH, BI Nutraceuticals, Nutra Green Biotechnology Co. Ltd., KuberImpex Ltd., and Mb-Holding GmbH & Co. Kg.
Browse in-depth Report on http://www.meticulousresearch.com/product/botanical-extracts-market-forecast-2022/
Scope of the report:
Market, By Source
- Spices
- Fruits
- Herbs
- Flowers
- Tea Leaves
Market, By Form
- Liquid
- Powder
Market, By Application
- Food
- Bakery and Confectionery
- Sauces and Dressings - Beverages
- Alcoholic Beverages
- Carbonated Soft Drinks
- Ice Tea
- Flavoured Dairy Products - Cosmetics
- Pharmaceutical
Contact Info
Viren Shrivastava
AVP- Global Sales and Marketing
Meticulous Research™
Email: [email protected]
Direct Lines: +1-646-781-8004 (North America)
+44-203-868-8738 (Europe)
+91 744-7780008 (Asia-Pacific)


OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 



